HG Infra has been declared as L1 bidder by National Highways Authority of India (NHAI), New Delhi for new EPC project for construction of 6-lane access.

Alembic Pharmaceuticals has announced that it has received approval from US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Acetazolamide Extended-Release Capsules, 500 mg.

Strides Pharma Science, Bengaluru-based pharma company announced that its step-down wholly-owned subsidiary, Strides Pharma Global Pte. Limited, Singapore has received USFDA approval for Ethosuximide Softgel Capsules.

Andhra Bank intends to sell its 30 per cent stake in IndiaFirst Life Insurance Company either in part or in full. By doing so, it aspires to raise Rs. 900 crore. One of the candidates who could potentially purchase the stake is the existing investor, Warburg Pincus.

Many financial advisers have been asking people to invest in mutual funds rather than real estate due to good returns in the long-term. So, should you dispose of your real estate investment and invest in mutual funds? Let’s find out.

Following stocks are close to their 52-weeks low as at 1.00 p.m. on February 20, 2019.

Aarti Industries has entered a supply contract with a leading global chemical conglomerate. The Rs. 900 crore contract includes the supply of a high-value speciality chemical intermediate for a period of 10 years.

The markets on February 20, 2019 opened gap up. BSE Sensex is trading at 35,520.11, up by 167.50 points and the Nifty is trading at 10,656.70, up by 52.35 points. 

Pharma major Dr. Reddy’s Labs won a legal battle against Indivior, a British drugmaker, in the US as the US Chief Justice allowed the company to resume selling the generic version of Suboxone Film which is Indiviors' opioid addiction treatment drug.

Benchmark indices were moving upward in the morning session on Wednesday. This was a broad based upmove with good participation from mid-cap and small-cap stocks. The market seemed to be reacting to global cues wherein the US markets gained on the back of good earnings and scheduled US Fed's policy meet.